Gut microbiota and digestion of polysaccharides;Le microbiote intestinal et la digestion des polysaccharides

Medecine/Sciences

Volumn 30, Issue 3, 2014, Pages 259-265

  El Kaoutari, Abdessamad ^a,c   Armougom, Fabrice ^c   Raoult, Didier ^c   Henrissat, Bernard ^a,b,d  

^a CNRS   (France)

^b Centre National de la Recherche Scientifique   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE;

ANIMAL; ARTICLE; BACTERIUM; DIGESTION; FERMENTATION; GASTROINTESTINAL TRACT; HUMAN; HYDROLYSIS; INTESTINE; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

ANIMALS; BACTERIA; DIGESTION; FERMENTATION; GASTROINTESTINAL TRACT; HUMANS; HYDROLYSIS; INTESTINES; MICROBIOTA; POLYSACCHARIDES;

EID: 84897475975     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/20143003013     Document Type: Article

References (45)

1. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
2. Consortium IHGS. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-945.
3. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 1999; 28: 19-25.
4. Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694-1697.
5. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 2012; 10: 323-335.
6. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638.
7. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486: 207-214.
8. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837-848.
9. Kurokawa K, Itoh T, Kuwahara T, et al. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007; 14: 169-181.
10. Turnbaugh PJ, Gordon JI. The core gut microbiome, energy balance and obesity. J Physiol 2009; 587: 4153-4158.
11. McNeil NI. The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 1984; 39: 338-342.
12. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat Rev Immunol 2010; 10: 735-744.
13. Conroy ME, Shi HN, Walker WA. The long-term health effects of neonatal microbial flora. Curr Opin Allergy Clin Immunol 2009; 9: 197-201.
14. Guarner F, Malagelada J.R. Gut flora in health and disease. Lancet 2003; 361: 512-519.
15. Cantarel BL, Lombard V, Henrissat B. Complex carbohydrate utilization by the healthy human microbiome. PLoS One 2012; 7: e28742.
16. Cantarel BL, Coutinho PM, Rancurel C, et al. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res 2009; 37: D233-D238.
17. El Kaoutari A, Armougom F, Gordon JI, et al. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol 2013; 11: 497-504.
18. DeVries JW. On defining dietary fibre. Proc Nutr Soc 2003; 62: 37-43.
19. Gallant DJ, Bouchet B, Buleon A, Perez S. Physical characteristics of starch granules and susceptibility to enzymatic degradation. Eur J Clin Nutr 1992; 46 Suppl 2: S3-16.
20. Esko JD, Kimata K, Lindahl U. Proteoglycans and sulfated glycosaminoglycans, 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, 2009.
21. Martens EC, Lowe EC, Chiang H, et al. Recognition, degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol 2011; 9: e1001221.
22. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13: 517-526.
23. Vanhoutvin SA, Troost FJ, Hamer HM, et al. Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One 2009; 4: e6759.
24. Inan MS, Rasoulpour RJ, Yin L, et al. The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 2000; 118: 724-734.
25. Gao Z, Yin J, Zhang J, et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009; 58: 1509-1517.
26. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
27. Zupancic ML, Cantarel BL, Liu Z, et al. Analysis of the gut microbiota in the old order Amish, its relation to the metabolic syndrome. PLoS One 2012; 7: e43052.
28. Schwiertz A, Taras D, Schafer K, et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010; 18: 190-195.
29. Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 2013; 110: 9066-9071.
30. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
31. Ridaura VK, Faith JJ, Rey FE, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341: 1241214.
32. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55: 205-211.
33. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-16736.
34. Hansen R, Russell RK, Reiff C, et al. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012; 107: 1913-1922.
35. Jia W, Whitehead RN, Griffiths L, et al. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 2010; 310: 138-144.
36. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133: 24-33.
37. Sjogren YM, Jenmalm MC, Bottcher MF, et al. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy 2009; 39: 518-526.
38. Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005; 54: 987-991.
39. Meyer D, Stasse-Wolthuis M. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 2009; 63: 1277-1289.
40. Scott KP, Martin JC, Chassard C, et al. Substrate-driven gene expression in Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin, starch. Proc Natl Acad Sci USA 2011; 108: suppl 1 4672-4679.
41. McNulty NP, Yatsunenko T, Hsiao A, et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci Transl Med 2011; 3: 106ra.
42. Borody TJ, Warren EF, Leis S, et al. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 42-47.
43. Bernardo P, Albina E, Eloit M, Roumagnac P. Métagénomique virale et pathologie. Med Sci (Paris) 2013; 21: 501-508.
44. Burcelin R, Chabo C, Blasco-Baque V, et al. Le microbiote intestinal à l'origine de nouvelles perspectives thérapeutiques pour les maladies métaboliques ? Med Sci (Paris) 2013; 29: 800-806.
45. Korneychuk N. Les cellules lymphoïdes innées contrôlent la réponse adaptative aux bactéries commensales intestinales. Med Sci (Paris) 2014; 30: 253-257.